Literature DB >> 11761268

Multistage carcinogenesis in cell culture.

H Rubin1.   

Abstract

Rodent fibroblasts explanted from embryos to culture undergo a period of declining growth rate in serial passages leading to crisis, followed by the appearance of variants which can multiply indefinitely. If the "immortal" cell line was established by low density passage, i.e., 3T3 cells, it has a low saturation density and is non-tumorigenic. If it was established by high density passage, it has a high saturation density and is tumorigenic. The establishment of cells goes through successive stages, including increased capacity to multiply in low serum concentration, growth to high saturation density, growth in suspension, assisted tumour formation in susceptible hosts and unassisted tumour formation. Chromosome aberrations and aneuploidy occur long before the capacity to produce tumours appears. Contrary to conventional belief, human fibroblast populations also undergo a continuous loss of capacity to multiply from the time of explantation, with only the longest surviving clone reaching the Hayflick limit. Neoplastic transformation of rodent cells is strongly favoured by maintaining them in a quiescent state at confluence for prolonged periods, which results in genetic damage to the cells. It also produces a large variety of chromosomal aberrations in human cells and extends their replicative lifespan. Individual clones are more susceptible to spontaneous transformation than their heterogeneous parental cultures. The implications of these results for tumour development in vivo are that oncogenic genetic changes may be common under stressful conditions which restrict replication, and that such changes are maximized when a rogue clone reaches a critical size that reduces stabilizing interactions with neighbouring clones. An alternative explanation, described in the Addendum, which we retrospectively favor is that the easily transformed clones are a minority in the uncloned parental population. The reason they transform before the parental population is that when they are expanded, they have more transformable cells available under the selective condition of confluence than the uncloned parental population from which they are derived.

Entities:  

Mesh:

Year:  2001        PMID: 11761268

Source DB:  PubMed          Journal:  Dev Biol (Basel)        ISSN: 1424-6074


  14 in total

1.  Defining the probability that a cell therapy will produce a malignancy.

Authors:  Darwin J Prockop
Journal:  Mol Ther       Date:  2010-07       Impact factor: 11.454

2.  Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells.

Authors:  Benjamin L Larson; Joni Ylostalo; Ryang H Lee; Carl Gregory; Darwin J Prockop
Journal:  Tissue Eng Part A       Date:  2010-07-13       Impact factor: 3.845

Review 3.  Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions.

Authors:  Darwin J Prockop; Scott D Olson
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

Review 4.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

Review 5.  Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.

Authors:  Darwin J Prockop
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

6.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

7.  Should publications on mesenchymal stem/progenitor cells include in-process data on the preparation of the cells?

Authors:  Roxanne L Reger; Darwin J Prockop
Journal:  Stem Cells Transl Med       Date:  2014-04-01       Impact factor: 6.940

Review 8.  Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations.

Authors:  Darwin J Prockop; Joo Youn Oh
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

Review 9.  Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine.

Authors:  Natalia Vapniarsky; Boaz Arzi; Jerry C Hu; Jan A Nolta; Kyriacos A Athanasiou
Journal:  Stem Cells Transl Med       Date:  2015-08-07       Impact factor: 6.940

10.  Tumor Formation of Adult Stem Cell Transplants in Rodent Arthritic Joints.

Authors:  Fanny Chapelin; Aman Khurana; Mohammad Moneeb; Florette K Gray Hazard; Chun Fai Ray Chan; Hossein Nejadnik; Dita Gratzinger; Solomon Messing; Jason Erdmann; Amitabh Gaur; Heike E Daldrup-Link
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.